共 27 条
- [1] BABINE R, 2002, Patent No. 0218369
- [2] NEW METHOD FOR DEOXYGENATION OF SECONDARY ALCOHOLS[J]. BARTON, DHR;MCCOMBIE, SW. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1975(16)
- [3] The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: Segment coupling and stepwise peptide assembly[J]. Carpino, LA;El-Faham, A. TETRAHEDRON, 1999(22)
- [4] CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062
- [5] PYBOP - A NEW PEPTIDE COUPLING REAGENT DEVOID OF TOXIC BY-PRODUCT[J]. COSTE, J;LENGUYEN, D;CASTRO, B. TETRAHEDRON LETTERS, 1990(02)
- [6] COUCH RB, 1990, VIROLOGY
- [7] READILY ACCESSIBLE 12-I-5 OXIDANT FOR THE CONVERSION OF PRIMARY AND SECONDARY ALCOHOLS TO ALDEHYDES AND KETONES[J]. DESS, DB;MARTIN, JC. JOURNAL OF ORGANIC CHEMISTRY, 1983(22)
- [8] Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors[J]. Dragovich, PS;Zhou, R;Webber, SE;Prins, TJ;Kwok, AK;Okano, K;Fuhrman, SA;Zalman, LS;Maldonado, FC;Brown, EL;Meador, JW;Patick, AK;Ford, CE;Brothers, MA;Binford, SL;Matthews, DA;Ferre, RA;Worland, ST. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000(01)
- [9] Recent advances in the development of human rhinovirus 3C protease inhibitors[J]. Dragovich, PS. EXPERT OPINION ON THERAPEUTIC PATENTS, 2001(02)
- [10] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.: 4.: Incorporation of P1 lactam moieties as L-glutamine replacements[J]. Dragovich, PS;Prins, TJ;Zhou, R;Webber, SE;Marakovits, JT;Fuhrman, SA;Patick, AK;Matthews, DA;Lee, CA;Ford, CE;Burke, BJ;Rejto, PA;Hendrickson, TF;Tuntland, T;Brown, EL;Meador, JW;Ferre, RA;Harr, JEV;Kosa, MB;Worland, ST. JOURNAL OF MEDICINAL CHEMISTRY, 1999(07)